Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Ozlem Aslan, Mattia Cremona, Clare Morgan, Lydia W. Cheung, Gordon B. Mills, Bryan T. Hennessy

ABSTRACT

BACKGROUND: The phosphoinositide-3-kinase (PI3K) pathway is the most commonly activated pathway in cancers due to mutations at multiple nodes and loss of PTEN. Furthermore, in endometrial cancer (EC), PI3K and RAS/RAF/MEK/MAPK (RAS/MAPK herein) pathway mutations frequently co-exist. We examined the role of PI3K and RAS/MAPK pathway mutations in determining responsiveness to therapies targeted to these pathways in vitro in EC. METHODS: 13 EC cell lines were profiled for their PI3K pathway and KRAS mutational and PTEN protein status and treated with one MEK- and two PI3K- targeted inhibitors alone and in combination. Expression and phosphorylation of 66 proteins were evaluated by Reverse-Phase-Protein-Array (RPPA) in 6 EC cell lines to identify signalling changes in these pathways in response to therapy. RESULTS: PTEN protein loss and the absence of any tested pathway mutations are dominant negative predictors of sensitivity to MEK inhibition. KRAS-mutated cells were most sensitive to MEK inhibition, but significantly more resistant to PI3K inhibition than KRAS-wild-type cell lines. Combinations of PI3K and MEK inhibitors showed synergy or additivity in all but two cell lines tested. Treatment of KRAS-mutated cells with PI3K inhibitors and treatment of PTEN-low cells with a MEK inhibitor were most likely to induce activation of MEK/MAPK and AKT, respectively, likely indicative of feedback-loop regulation. CONCLUSIONS: MEK inhibition may be a promising treatment modality, not just for ECs with mutated KRAS, but also for those with retained PTEN. Up-regulation of MEK/MAPK signalling by PI3K inhibition, and up-regulation of AKT activation by MEK inhibition may serve as potential biomarkers of likely responsiveness to each inhibitor. More... »

PAGES

168

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-018-4035-0

DOI

http://dx.doi.org/10.1186/s12885-018-4035-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1100920047

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29426295


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endometrial Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MAP Kinase Signaling System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphatidylinositol 3-Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aslan", 
        "givenName": "Ozlem", 
        "id": "sg:person.01127750423.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127750423.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cremona", 
        "givenName": "Mattia", 
        "id": "sg:person.01254453536.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254453536.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morgan", 
        "givenName": "Clare", 
        "id": "sg:person.01333422210.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333422210.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Systems Biology, the University of Texas M.D. Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheung", 
        "givenName": "Lydia W.", 
        "id": "sg:person.010275126012.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010275126012.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Systems Biology, the University of Texas M.D. Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mills", 
        "givenName": "Gordon B.", 
        "id": "sg:person.012742742357.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012742742357.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hennessy", 
        "givenName": "Bryan T.", 
        "id": "sg:person.01153534336.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153534336.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrd1902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000136134", 
          "https://doi.org/10.1038/nrd1902"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd1902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000136134", 
          "https://doi.org/10.1038/nrd1902"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-0317", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000149673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-07-6854", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002831536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-9966-33-52", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003227335", 
          "https://doi.org/10.1186/1756-9966-33-52"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature12113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004984574", 
          "https://doi.org/10.1038/nature12113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-14-120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005813809", 
          "https://doi.org/10.1186/1471-2407-14-120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-11-0446", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008468709"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molonc.2012.12.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008768662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-0850", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012692937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7827-5-38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014481930", 
          "https://doi.org/10.1186/1477-7827-5-38"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.humpath.2006.05.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015533018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-09-4172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016732483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pas.0b013e31828c63ed", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019283692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pas.0b013e31828c63ed", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019283692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.01172.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021156413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.01172.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021156413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0065-2571(84)90007-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026371633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0065-2571(84)90007-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026371633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2007.03.051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027154726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-12-3815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029733003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-2620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032388482"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/2159-8290.cd-11-0039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033852076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2015.05.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035391309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gr.137596.112", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036133518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-07-0760", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036144328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00749057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038519975", 
          "https://doi.org/10.1007/bf00749057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00749057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038519975", 
          "https://doi.org/10.1007/bf00749057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2015.04.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042797119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-06-0334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045065073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2015.190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047136649", 
          "https://doi.org/10.1038/bjc.2015.190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-10-1707", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047552330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/bioinformatics/btn663", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049706764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/gb-2013-14-4-r37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050616857", 
          "https://doi.org/10.1186/gb-2013-14-4-r37"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.36.1196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051416200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-11-1515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052103939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-11-0549", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053740385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm800295d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055955582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm800295d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055955582"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: The phosphoinositide-3-kinase (PI3K) pathway is the most commonly activated pathway in cancers due to mutations at multiple nodes and loss of PTEN. Furthermore, in endometrial cancer (EC), PI3K and RAS/RAF/MEK/MAPK (RAS/MAPK herein) pathway mutations frequently co-exist. We examined the role of PI3K and RAS/MAPK pathway mutations in determining responsiveness to therapies targeted to these pathways in vitro in EC.\nMETHODS: 13 EC cell lines were profiled for their PI3K pathway and KRAS mutational and PTEN protein status and treated with one MEK- and two PI3K- targeted inhibitors alone and in combination. Expression and phosphorylation of 66 proteins were evaluated by Reverse-Phase-Protein-Array (RPPA) in 6 EC cell lines to identify signalling changes in these pathways in response to therapy.\nRESULTS: PTEN protein loss and the absence of any tested pathway mutations are dominant negative predictors of sensitivity to MEK inhibition. KRAS-mutated cells were most sensitive to MEK inhibition, but significantly more resistant to PI3K inhibition than KRAS-wild-type cell lines. Combinations of PI3K and MEK inhibitors showed synergy or additivity in all but two cell lines tested. Treatment of KRAS-mutated cells with PI3K inhibitors and treatment of PTEN-low cells with a MEK inhibitor were most likely to induce activation of MEK/MAPK and AKT, respectively, likely indicative of feedback-loop regulation.\nCONCLUSIONS: MEK inhibition may be a promising treatment modality, not just for ECs with mutated KRAS, but also for those with retained PTEN. Up-regulation of MEK/MAPK signalling by PI3K inhibition, and up-regulation of AKT activation by MEK inhibition may serve as potential biomarkers of likely responsiveness to each inhibitor.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-018-4035-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2440196", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro", 
    "pagination": "168", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a537b1870eab658d150959da1e9d9ce56a384d094329d8713b85c0090aacccd8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29426295"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-018-4035-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1100920047"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-018-4035-0", 
      "https://app.dimensions.ai/details/publication/pub.1100920047"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000493.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186/s12885-018-4035-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4035-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4035-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4035-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-018-4035-0'


 

This table displays all metadata directly associated to this object as RDF triples.

258 TRIPLES      21 PREDICATES      71 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-018-4035-0 schema:about N57c99c6e3087463d9455de519f07697f
2 N587a1844dcbf4eda9653d872ea09308c
3 N5b80d1174c2e48808b063b87ee92f04e
4 N60ca27e1de754c09bdc51ac7d49f10ee
5 N71174f4466024d4fadcd089453fbb898
6 N7ebc6d686a2c462688d0e41d1fadca65
7 N9ec890cbbec841cb940385741bbdac4d
8 Na202f8b1cdd64439b083270e0005ca55
9 Nabce51adea544d73a2ad1621d7a548a7
10 anzsrc-for:06
11 anzsrc-for:0601
12 schema:author Nbe1609b64b1d492fb65462e57ff359f7
13 schema:citation sg:pub.10.1007/bf00749057
14 sg:pub.10.1038/bjc.2015.190
15 sg:pub.10.1038/nature12113
16 sg:pub.10.1038/nrd1902
17 sg:pub.10.1186/1471-2407-14-120
18 sg:pub.10.1186/1477-7827-5-38
19 sg:pub.10.1186/1756-9966-33-52
20 sg:pub.10.1186/gb-2013-14-4-r37
21 https://doi.org/10.1016/0065-2571(84)90007-4
22 https://doi.org/10.1016/j.cell.2007.03.051
23 https://doi.org/10.1016/j.humpath.2006.05.007
24 https://doi.org/10.1016/j.molonc.2012.12.007
25 https://doi.org/10.1016/j.ygyno.2015.04.028
26 https://doi.org/10.1016/j.ygyno.2015.05.031
27 https://doi.org/10.1021/jm800295d
28 https://doi.org/10.1093/bioinformatics/btn663
29 https://doi.org/10.1097/pas.0b013e31828c63ed
30 https://doi.org/10.1101/gr.137596.112
31 https://doi.org/10.1111/j.1525-1438.2007.01172.x
32 https://doi.org/10.1158/0008-5472.can-05-2620
33 https://doi.org/10.1158/0008-5472.can-07-6854
34 https://doi.org/10.1158/0008-5472.can-09-4172
35 https://doi.org/10.1158/0008-5472.can-11-0549
36 https://doi.org/10.1158/0008-5472.can-11-1515
37 https://doi.org/10.1158/1078-0432.ccr-07-0760
38 https://doi.org/10.1158/1078-0432.ccr-09-0317
39 https://doi.org/10.1158/1078-0432.ccr-10-1707
40 https://doi.org/10.1158/1078-0432.ccr-12-3815
41 https://doi.org/10.1158/1078-0432.ccr-13-0850
42 https://doi.org/10.1158/1535-7163.mct-06-0334
43 https://doi.org/10.1158/1535-7163.mct-11-0446
44 https://doi.org/10.1158/2159-8290.cd-11-0039
45 https://doi.org/10.1200/jco.2011.36.1196
46 schema:datePublished 2018-12
47 schema:datePublishedReg 2018-12-01
48 schema:description BACKGROUND: The phosphoinositide-3-kinase (PI3K) pathway is the most commonly activated pathway in cancers due to mutations at multiple nodes and loss of PTEN. Furthermore, in endometrial cancer (EC), PI3K and RAS/RAF/MEK/MAPK (RAS/MAPK herein) pathway mutations frequently co-exist. We examined the role of PI3K and RAS/MAPK pathway mutations in determining responsiveness to therapies targeted to these pathways in vitro in EC. METHODS: 13 EC cell lines were profiled for their PI3K pathway and KRAS mutational and PTEN protein status and treated with one MEK- and two PI3K- targeted inhibitors alone and in combination. Expression and phosphorylation of 66 proteins were evaluated by Reverse-Phase-Protein-Array (RPPA) in 6 EC cell lines to identify signalling changes in these pathways in response to therapy. RESULTS: PTEN protein loss and the absence of any tested pathway mutations are dominant negative predictors of sensitivity to MEK inhibition. KRAS-mutated cells were most sensitive to MEK inhibition, but significantly more resistant to PI3K inhibition than KRAS-wild-type cell lines. Combinations of PI3K and MEK inhibitors showed synergy or additivity in all but two cell lines tested. Treatment of KRAS-mutated cells with PI3K inhibitors and treatment of PTEN-low cells with a MEK inhibitor were most likely to induce activation of MEK/MAPK and AKT, respectively, likely indicative of feedback-loop regulation. CONCLUSIONS: MEK inhibition may be a promising treatment modality, not just for ECs with mutated KRAS, but also for those with retained PTEN. Up-regulation of MEK/MAPK signalling by PI3K inhibition, and up-regulation of AKT activation by MEK inhibition may serve as potential biomarkers of likely responsiveness to each inhibitor.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree true
52 schema:isPartOf N91c0fa8ba42d46caaaf5ceb3e223725b
53 Nc9ed6b101f864bd7b3d8ed711f00e2a9
54 sg:journal.1024632
55 schema:name Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro
56 schema:pagination 168
57 schema:productId N3b5decf107cc47b9a73f6c5c03d99478
58 N642ea93f90ca494989dfb4c60deca9ec
59 N733054bb71f34e888ed2b1591c5f3257
60 N9925d21437a84dbba806526b5691e293
61 Nbf40a48d239b481f83923cc3cc296595
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100920047
63 https://doi.org/10.1186/s12885-018-4035-0
64 schema:sdDatePublished 2019-04-10T14:56
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher N0226a921fe2a49d194cc8133a4097835
67 schema:url http://link.springer.com/10.1186/s12885-018-4035-0
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N0226a921fe2a49d194cc8133a4097835 schema:name Springer Nature - SN SciGraph project
72 rdf:type schema:Organization
73 N022f956526e44b438579e6cd75b82b07 rdf:first sg:person.012742742357.13
74 rdf:rest N7cd11791de404da88cb183e999727b3e
75 N1f95adad90db4afc8a40683c1faab0e0 schema:name Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
76 rdf:type schema:Organization
77 N3b5decf107cc47b9a73f6c5c03d99478 schema:name pubmed_id
78 schema:value 29426295
79 rdf:type schema:PropertyValue
80 N47d650c2a6064678b2dd4cb5fd5c4fff rdf:first sg:person.01333422210.25
81 rdf:rest Ne0ace947dd48401dacf31764761fe93b
82 N57c99c6e3087463d9455de519f07697f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Antineoplastic Agents
84 rdf:type schema:DefinedTerm
85 N587a1844dcbf4eda9653d872ea09308c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Humans
87 rdf:type schema:DefinedTerm
88 N5b80d1174c2e48808b063b87ee92f04e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name MAP Kinase Signaling System
90 rdf:type schema:DefinedTerm
91 N60ca27e1de754c09bdc51ac7d49f10ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Cell Survival
93 rdf:type schema:DefinedTerm
94 N642ea93f90ca494989dfb4c60deca9ec schema:name dimensions_id
95 schema:value pub.1100920047
96 rdf:type schema:PropertyValue
97 N70a46d505f4a4403b869d82979a0b442 rdf:first sg:person.01254453536.69
98 rdf:rest N47d650c2a6064678b2dd4cb5fd5c4fff
99 N71174f4466024d4fadcd089453fbb898 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Phosphatidylinositol 3-Kinases
101 rdf:type schema:DefinedTerm
102 N733054bb71f34e888ed2b1591c5f3257 schema:name nlm_unique_id
103 schema:value 100967800
104 rdf:type schema:PropertyValue
105 N7cd11791de404da88cb183e999727b3e rdf:first sg:person.01153534336.84
106 rdf:rest rdf:nil
107 N7ebc6d686a2c462688d0e41d1fadca65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Cell Line, Tumor
109 rdf:type schema:DefinedTerm
110 N91c0fa8ba42d46caaaf5ceb3e223725b schema:volumeNumber 18
111 rdf:type schema:PublicationVolume
112 N9788d9bfa5014e7983540fc8ccd92ab2 schema:name Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
113 rdf:type schema:Organization
114 N9925d21437a84dbba806526b5691e293 schema:name readcube_id
115 schema:value a537b1870eab658d150959da1e9d9ce56a384d094329d8713b85c0090aacccd8
116 rdf:type schema:PropertyValue
117 N9ec890cbbec841cb940385741bbdac4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Protein Kinase Inhibitors
119 rdf:type schema:DefinedTerm
120 Na202f8b1cdd64439b083270e0005ca55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Endometrial Neoplasms
122 rdf:type schema:DefinedTerm
123 Nabce51adea544d73a2ad1621d7a548a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Female
125 rdf:type schema:DefinedTerm
126 Nb153d1a8aaec4642829009a7e713f0db schema:name Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
127 rdf:type schema:Organization
128 Nbe1609b64b1d492fb65462e57ff359f7 rdf:first sg:person.01127750423.20
129 rdf:rest N70a46d505f4a4403b869d82979a0b442
130 Nbf40a48d239b481f83923cc3cc296595 schema:name doi
131 schema:value 10.1186/s12885-018-4035-0
132 rdf:type schema:PropertyValue
133 Nc9ed6b101f864bd7b3d8ed711f00e2a9 schema:issueNumber 1
134 rdf:type schema:PublicationIssue
135 Ne0ace947dd48401dacf31764761fe93b rdf:first sg:person.010275126012.49
136 rdf:rest N022f956526e44b438579e6cd75b82b07
137 Ne49503c8bab24c77879f5aecbf4a4183 schema:name Department of Medical Oncology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
138 rdf:type schema:Organization
139 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
140 schema:name Biological Sciences
141 rdf:type schema:DefinedTerm
142 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
143 schema:name Biochemistry and Cell Biology
144 rdf:type schema:DefinedTerm
145 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-018-4035-0
146 rdf:type schema:MonetaryGrant
147 sg:grant.2440196 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-018-4035-0
148 rdf:type schema:MonetaryGrant
149 sg:journal.1024632 schema:issn 1471-2407
150 schema:name BMC Cancer
151 rdf:type schema:Periodical
152 sg:person.010275126012.49 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
153 schema:familyName Cheung
154 schema:givenName Lydia W.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010275126012.49
156 rdf:type schema:Person
157 sg:person.01127750423.20 schema:affiliation Nb153d1a8aaec4642829009a7e713f0db
158 schema:familyName Aslan
159 schema:givenName Ozlem
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127750423.20
161 rdf:type schema:Person
162 sg:person.01153534336.84 schema:affiliation N9788d9bfa5014e7983540fc8ccd92ab2
163 schema:familyName Hennessy
164 schema:givenName Bryan T.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153534336.84
166 rdf:type schema:Person
167 sg:person.01254453536.69 schema:affiliation N1f95adad90db4afc8a40683c1faab0e0
168 schema:familyName Cremona
169 schema:givenName Mattia
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254453536.69
171 rdf:type schema:Person
172 sg:person.012742742357.13 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
173 schema:familyName Mills
174 schema:givenName Gordon B.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012742742357.13
176 rdf:type schema:Person
177 sg:person.01333422210.25 schema:affiliation Ne49503c8bab24c77879f5aecbf4a4183
178 schema:familyName Morgan
179 schema:givenName Clare
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333422210.25
181 rdf:type schema:Person
182 sg:pub.10.1007/bf00749057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038519975
183 https://doi.org/10.1007/bf00749057
184 rdf:type schema:CreativeWork
185 sg:pub.10.1038/bjc.2015.190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047136649
186 https://doi.org/10.1038/bjc.2015.190
187 rdf:type schema:CreativeWork
188 sg:pub.10.1038/nature12113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004984574
189 https://doi.org/10.1038/nature12113
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/nrd1902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000136134
192 https://doi.org/10.1038/nrd1902
193 rdf:type schema:CreativeWork
194 sg:pub.10.1186/1471-2407-14-120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005813809
195 https://doi.org/10.1186/1471-2407-14-120
196 rdf:type schema:CreativeWork
197 sg:pub.10.1186/1477-7827-5-38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014481930
198 https://doi.org/10.1186/1477-7827-5-38
199 rdf:type schema:CreativeWork
200 sg:pub.10.1186/1756-9966-33-52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003227335
201 https://doi.org/10.1186/1756-9966-33-52
202 rdf:type schema:CreativeWork
203 sg:pub.10.1186/gb-2013-14-4-r37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050616857
204 https://doi.org/10.1186/gb-2013-14-4-r37
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/0065-2571(84)90007-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026371633
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/j.cell.2007.03.051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027154726
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/j.humpath.2006.05.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015533018
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/j.molonc.2012.12.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008768662
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/j.ygyno.2015.04.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042797119
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/j.ygyno.2015.05.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035391309
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1021/jm800295d schema:sameAs https://app.dimensions.ai/details/publication/pub.1055955582
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/bioinformatics/btn663 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049706764
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/pas.0b013e31828c63ed schema:sameAs https://app.dimensions.ai/details/publication/pub.1019283692
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1101/gr.137596.112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036133518
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1111/j.1525-1438.2007.01172.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021156413
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1158/0008-5472.can-05-2620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032388482
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1158/0008-5472.can-07-6854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002831536
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1158/0008-5472.can-09-4172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016732483
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1158/0008-5472.can-11-0549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053740385
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1158/0008-5472.can-11-1515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052103939
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1158/1078-0432.ccr-07-0760 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036144328
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1158/1078-0432.ccr-09-0317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000149673
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1158/1078-0432.ccr-10-1707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047552330
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1158/1078-0432.ccr-12-3815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029733003
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1158/1078-0432.ccr-13-0850 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012692937
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1158/1535-7163.mct-06-0334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045065073
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1158/1535-7163.mct-11-0446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008468709
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1158/2159-8290.cd-11-0039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033852076
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1200/jco.2011.36.1196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051416200
255 rdf:type schema:CreativeWork
256 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
257 schema:name Department of Systems Biology, the University of Texas M.D. Anderson Cancer Center, 77030, Houston, TX, USA
258 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...